Methazolamide Pregnancy and Breastfeeding Warnings
Brand names: Glauctabs, MZM, Neptazane
Medically reviewed by Drugs.com. Last updated on Aug 9, 2023.
Methazolamide Pregnancy Warnings
This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus.
US FDA pregnancy category: C
Animal studies have revealed evidence of teratogenicity. There are not controlled data in human pregnancy.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Methazolamide Breastfeeding Warnings
A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments: The effects in the nursing infant are unknown.
See also
References for pregnancy information
- Product Information. Neptazane (methazolamide). Wyeth-Ayerst Laboratories. 2006.
References for breastfeeding information
- Product Information. Neptazane (methazolamide). Wyeth-Ayerst Laboratories. 2006.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
